Načítá se...
Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration
Background/aim: Age related macular degeneration (AMD) is the leading cause of severe vision impairment and blindness in older people throughout the developed world and currently affects around 420 000 UK citizens. Choroidal neovascularisation (CNV) is treatable with photodynamic therapy (PDT) but i...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Copyright 2004 British Journal of Ophthalmology
2004
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1772258/ https://ncbi.nlm.nih.gov/pubmed/15258009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2003.039131 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|